Category - Hot Stocks

Market Pulse: Tech enthusiasm nudged U.S. futures higher after global benchmarks closed mixed on Tuesday, setting a cautiously optimistic tone. Key Movers: SpaceX’s looming flotation hype and Starlink buzz fueled the rally, while...

Dividend Policy & History Ascentage Pharma Group International (NASDAQ: AAPG) is a clinical-stage biopharmaceutical company focused on oncology and related diseases ([1]). As is typical for growth-focused biotech firms, AAPG has...

Market Pulse: Markets drifted in place yesterday as U.S. and European shares barely budged, while Bitcoin peeled off exchanges in a long-term accumulation story that belies near-term bumpiness. Key Movers: Revolut’s 30%...

Company & Pipeline Overview Autolus Therapeutics (Nasdaq: AUTL) is a UK-based biotechnology company focused on CAR-T cell therapies for cancer and autoimmune diseases ([1]). The company recently transitioned to “early commercial...

Market Pulse: Equities edged mixed as tech flirted with volatility and IPO buzz kept retail eyes fixed on debut listings. Key Movers: Coinbase’s India relaunch and Airwallex’s $8 billion valuation refocused institutional flows...

Company Overview Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company serving a wide range of consumer and industrial markets, including pharmaceuticals, personal care, food & beverage, coatings...

Opening Recap Market Pulse: Heavyweights flexed their muscle again yesterday, sending the headline index hovering near 26K even as most portfolios drifted sideways or slipped into the red. Key Movers: Tata Consultancy Services...

Context and JPMorgan’s Revised Outlook JPMorgan has refreshed its view on Hormel Foods (NYSE: HRL) following the company’s latest earnings and guidance. Analyst Thomas Palmer maintains an Overweight rating and recently raised the...

This Morning's Snapshot Market Pulse: AI-driven crypto speculation and biotech restructuring tugged at sentiment overnight, sending risk assets on a roller-coaster while traditional sectors stayed on the sidelines. Key Movers:...

Company Overview and Pipeline CG Oncology, Inc. (NASDAQ: CGON) is a clinical-stage biopharmaceutical company specializing in bladder cancer therapies. Its lead product is cretostimogene (also known as CG0070), an oncolytic...